SPHERA GLOBAL HEALTHCARE FUND
Sphera Global Healthcare Management (Investment Manager) is a partnership between Mr. Mori Arkin, former vice chairman of Perrigo (Nasdaq ticker:PRGO, a world leader in generic and OTC drugs), and of Sphera Funds Management. It is a long/short equity fund that is focused on the global pharmaceutical and biotech industries. The Investment Managerโs objective is to generate consistent and attractive long term returns exceeding the industry while maintaining disciplined risk management. With a... highly experienced and cohesive multidisciplinary team, the Fundโs competitive advantage is evident in three key areas: โข Having a rigorous, fundamental, focused and comprehensive approach to healthcare research. โข Investment committee co- led by an industry veteran with a track record of building a pharmaceutical company. โข Unique and unbiased investment approach generated in part from access to massive flow of R &D, innovation and top tier human capital in Israel.
SPHERA GLOBAL HEALTHCARE FUND
Industry:
Financial Services
Founded:
2004-01-01
Status:
Active
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network Google Universal Analytics Font Awesome Global Site Tag
Similar Organizations
RA Capital Management
RA Capital Management is an investment advisor specializing in the life-sciences and drug development sectors.
Section 32
Section 32 is a venture capital fund that invests at the cutting edge of technology, healthcare, and life sciences.
Current Employees Featured
Founder
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2021-09-29 | BioAtla | Sphera Global Healthcare Fund investment in Post-IPO Equity - BioAtla | 75 M USD |
2021-07-19 | Frontier Medicines | Sphera Global Healthcare Fund investment in Series B - Frontier Medicines | 88.5 M USD |
2021-07-01 | Point Biopharma | Sphera Global Healthcare Fund investment in Post-IPO Equity - Point Biopharma | 165 M USD |
2021-03-30 | Immune-Onc Therapeutics | Sphera Global Healthcare Fund investment in Series B - Immune-Onc Therapeutics | 73 M USD |
2021-01-07 | Werewolf Therapeutics | Sphera Global Healthcare Fund investment in Series B - Werewolf Therapeutics | 72 M USD |
2020-12-15 | Yumanity Therapeutics | Sphera Global Healthcare Fund investment in Venture Round - Yumanity Therapeutics | 33.6 M USD |
2020-10-29 | LianBio | Sphera Global Healthcare Fund investment in Series A - LianBio | 310 M USD |
2020-09-04 | I-Mab Biopharma | Sphera Global Healthcare Fund investment in Post-IPO Equity - I-Mab Biopharma | 418 M USD |
2020-08-18 | Chinook Therapeutics | Sphera Global Healthcare Fund investment in Post-IPO Equity - Chinook Therapeutics | 106 M USD |
2020-08-10 | ESSA Pharma | Sphera Global Healthcare Fund investment in Post-IPO Equity - ESSA Pharma | 55.89 M USD |